Eisai Co., Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan.

We define our corporate mission as “giving first thought to patients and their families and to increasing the benefits health care provides,” which we call our human health care (hhc) philosophy. With approximately 10,000 employees working across our global network of R&D facilities, manufacturing sites and marketing subsidiaries, we strive to realize our hhc philosophy by delivering innovative products to address unmet medical needs, with a particular focus in our strategic areas of Neurology and Oncology.

Based on this hhc philosophy, all employees thoroughly conduct business activities that comply with laws and ethics and we aim to be a human health care (hhc) company capable of making a meaningful contribution under any health care system. In order to realize our corporate philosophy, looking towards the achievement of a sustainable society, it is necessary to implement corporate measures based on a long-term perspective under enhanced governance. We acknowledge that it is extremely important for our company to actively address global environmental and social issues and contribute to the sustainability of society.

COLLABORATIONS

SHOWING 5 of 18 COLLABORATIONS

See All

Access Accelerated Initiative

Tackling the growing burden of non-communicable diseases in low and middle-income countries and supporting...

Access Accelerated, Almirall, Astellas Pharma Inc, Bayer AG, Bristol-Myers Squibb, Celgene, Chiesi Farmaceutici, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., IFPMA, Johnson & Johnson, Menarini Group, Merck, MSD, Novartis, Pfizer Inc, Sanofi, Servier, Shionogi & Co., Ltd., Sumitomo Dainippon, Takeda Pharmaceutical Company Limited, UCB

SHOWING 5 of 18 COLLABORATIONS

See All